Skip Navigation
Skip to contents




17 results

Comparison of the AIMS65 Score with Other Risk Stratification Scores in Upper Variceal and Nonvariceal Gastrointestinal Bleeding

Alexandrino G, Carvalho R, Reis J

  • Gut Liver.
  • 2018 Jan;12(1):111-113.
  • doi: 10.5009/gnl17380
No abstract available.
Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy

Lee JW, Kim YT, Lee SH, Son JH, Kang JW, Ryu JK, Jang DK, Paik WH, Lee BS

  • Gut Liver.
  • 2018 Jan;12(1):102-110.
  • doi: 10.5009/gnl16588
BACKGROUND/AIMS: To determine the prognostic value of carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 in gallbladder cancer (GBC) during palliative chemotherapy. METHODS: One hundred and twenty-three patients with pathologically confirmed...
Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms

Lee YS, Seo YS, Kim JH, Lee J, Kim HR, Yoo YJ, Kim TS, Kang SH, Suh SJ, Joo MK, Jung YK, Lee BJ, Yim HJ, Yeon JE, Kim JS, Park JJ, Um SH, Bak YT, Byun KS

  • Gut Liver.
  • 2018 Jan;12(1):94-101.
  • doi: 10.5009/gnl17040
BACKGROUND/AIMS: In addition to the globally endorsed Barcelona Clinic Liver Cancer (BCLC) staging system, other algorithms or staging systems have been developed, including the Hong Kong Liver Cancer (HKLC) staging...
The Real-World Safety and Efficacy of Daclatasvir and Asunaprevir for Elderly Patients

Taki S, Tamai H, Ida Y, Shingaki N, Kawashima , Shimizu R, Moribata K, Maekita T, Iguchi M, Kato J, Nakao T, Kitano M

  • Gut Liver.
  • 2018 Jan;12(1):86-93.
  • doi: 10.5009/gnl17048
BACKGROUND/AIMS: Although daclatasvir with asunaprevir was approved in Japan for interferon ineligible or intolerant patients, patients aged ≥75 years were excluded in the phase III trial. The present study aimed...
Non-hypervascular Hypointense Nodules on Hepatocyte Phase Gadoxetic Acid-Enhanced MR Images: Transformation of MR Hepatobiliary Hypointense Nodules into Hypervascular Hepatocellular Carcinomas

Cho YK, Kim JW, Kim MY, Cho HJ

  • Gut Liver.
  • 2018 Jan;12(1):79-85.
  • doi: 10.5009/gnl17046
BACKGROUND/AIMS: The annual risk of transformation of non-hypervascular magnetic resonance (MR) hepatobiliary phase imaging (HBPI) hypointense nodules into hypervascular hepatocellular carcinomas (HCCs) was evaluated. METHODS: Cirrhotic patients with non-hypervascular HBPI hypointense...
Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease: A Randomized Controlled Clinical Trial

Zhang J, Lv S, Liu X, Song B, Shi L

  • Gut Liver.
  • 2018 Jan;12(1):73-78.
  • doi: 10.5009/gnl17035
BACKGROUND/AIMS: Stem cell therapy has been applied to treat a variety of autoimmune diseases, including Crohn's disease (CD), but few studies have examined the use of umbilical cord mesenchymal stem...
The Clinical Characteristics and Prognosis of Crohn's Disease in Korean Patients Showing Proximal Small Bowel Involvement: Results from the CONNECT Study

Kim OZ, Han DS, Park CH, Eun CS, Kim YS, Kim YH, Cheon JH, Ye BD, Kim JS

  • Gut Liver.
  • 2018 Jan;12(1):67-72.
  • doi: 10.5009/gnl16500
BACKGROUND/AIMS: We aimed to evaluate the clinical characteristics and prognosis of Crohn's disease (CD) in patients who showed proximal small bowel involvement using a nationwide Korean CD cohort. METHODS: We reviewed...
Helicobacter pylori Is Associated with miR-133a Expression through Promoter Methylation in Gastric Carcinogenesis

Lim JH, Kim SG, Choi JM, Yang HJ, Kim JS, Jung HC

  • Gut Liver.
  • 2018 Jan;12(1):58-66.
  • doi: 10.5009/gnl17263
BACKGROUND/AIMS: To investigate whether Helicobacter pylori eradication can reverse epigenetic silencing of microRNAs (miRNAs) which are associated with H. pylori-induced gastric carcinogenesis. METHODS: We examined expression and promoter methylation of miR-34b/c,...
Characterizing Helicobacter pylori cagA in Myanmar

Myint T, Miftahussurur M, Vilaichone Rk, Ni N, Aye TT, Subsomwong P, Uchida T, Mahachai V, Yamaoka Y

  • Gut Liver.
  • 2018 Jan;12(1):51-57.
  • doi: 10.5009/gnl17053
BACKGROUND/AIMS: Differences in the Helicobacter pylori infection rate are not sufficient to clarify the dissimilarity of gastric cancer incidence between Myanmar and its neighboring countries. To better understand this trend,...
Additive Effects of Rebamipide Plus Proton Pump Inhibitors on the Expression of Tight Junction Proteins in a Rat Model of Gastro-Esophageal Reflux Disease

Gweon TG, Park JH, Kim BW, Choi YK, Kim JS, Park SM, Kim CW, Kim HG, Chung JW, Incheon and Western Kyonggi Gastrointestinal Study Group

  • Gut Liver.
  • 2018 Jan;12(1):46-50.
  • doi: 10.5009/gnl17078
BACKGROUND/AIMS: The aim of this study was to investigate the effects of rebamipide on tight junction proteins in the esophageal mucosa in a rat model of gastroesophageal reflux disease (GERD). METHODS:...
Knowledge Gaps among Physicians Caring for Multiethnic Populations at Increased Gastric Cancer Risk

Shah SC, Itzkowitz , Jandorf L

  • Gut Liver.
  • 2018 Jan;12(1):38-45.
  • doi: 10.5009/gnl17091
BACKGROUND/AIMS: Although gastric cancer (GC) prevalence in the United States overall is low, there is significantly elevated risk in certain racial/ethnic groups. Providers caring for high-risk populations may not be...
A Prospective Study of Eosinophilic Esophagitis and the Expression of Tight Junction Proteins in Patients with Gastroesophageal Reflux Disease Symptoms

Okimoto K, Arai M, Ishigami H, Saito K, Minemura S, Maruoka D, Matsumura , Nakagawa T, Katsuno T, Suzuki M, Nakatani Y, Yokosuka O

  • Gut Liver.
  • 2018 Jan;12(1):30-37.
  • doi: 10.5009/gnl16600
BACKGROUND/AIMS: Eosinophilic esophagitis (EoE) is often erroneously diagnosed as gastroesophageal reflux disease (GERD). The aim of this study is to investigate the prevalence of EoE and the expression of tight...
Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features

Palmela C, Peerani F, Castaneda , Torres J, Itzkowitz

  • Gut Liver.
  • 2018 Jan;12(1):17-29.
  • doi: 10.5009/gnl16510
Primary sclerosing cholangitis (PSC) is a chronic, progressive cholestatic disease that is associated with inflammatory bowel disease (IBD) in approximately 70% of cases. Although the pathogenesis is still unknown for...
Current Trends in the Management of Gastroesophageal Reflux Disease

Sandhu DS, Fass R

  • Gut Liver.
  • 2018 Jan;12(1):7-16.
  • doi: 10.5009/gnl16615
Gastroesophageal reflux disease (GERD) characterized by heartburn and/or regurgitation symptoms is one of the most common gastrointestinal disorders managed by gastroenterologists and primary care physicians. There has been an increase...
Can Umbilical Cord Mesenchymal Stem Cells Treatment Be a Hope for Patients with Refractory Crohn's Disease?

Kim Y

  • Gut Liver.
  • 2018 Jan;12(1):5-6.
  • doi: 10.5009/gnl17492
No abstract available.
Crohn's Disease with Jejunal Involvement as a Predictor of Long-Term Clinical Outcomes

Kim YS, Jung SA

  • Gut Liver.
  • 2018 Jan;12(1):3-4.
  • doi: 10.5009/gnl17386
No abstract available.
Understanding Gastric Cancer Risk Factors: We Need to Close the Gap

Hwang JH

  • Gut Liver.
  • 2018 Jan;12(1):1-2.
  • doi: 10.5009/gnl17503
No abstract available.

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: